• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Gelnique (oxybutynin chloride) 10% gel

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

WARNINGS and PRECAUTIONS

Central Nervous System Effects
  • A variety of CNS anticholinergic effects have been reported, including headache, dizziness, and somnolence.